UltraPulse SurgiTouch CO2 Laser System

Products	UltraPulse SurgiTouch CO2 Laser System
Company	Lumenis, Inc.
Item	UltraPulse SurgiTouch CO2 Laser System
Features	Automatic pre-set starting parameters, by specialty and by application. Suggests a delivery device, tailored to meet multiple surgical needs. Scans a highly focused laser beam over a predetermined spot size (potentially up to 15 mm). Char-free tissue effects in the Surgitouch and. Ultrapulse mode. Highest pulse energy and average power in the medical laser industry. Physician-selectable pulse energy settings (2 to 225 mJ). Delivery devices and accessories for every specialty. Easy-to-maneuver, compact design and convenient storage. Easy-to-use touch screen controls with large control display. Clinical education staff for training and support.
Description	The UltraPulse system's capability to quickly deliver up to 250 millijoules of energy in one pulse allows for powerful single-pulse ablation. This type of high-energy pulse makes the UltraPulse system the coldest and cleanest CO2 surgical laser available today. When the pulse power is combined with the independent adjustment of pulse energy and operating speed, the clinician is given precise control of the laser. The pulsed energy acts like a blend control, allowing the clinician to select the volume of tissue ablation. The average power determines the rate of pulse arrival and controls the overall rate of tissue removal, so tissue effect can be customized at any speed, achieving superior control with reduced potential for charring.
Info	Lumenis, Inc. Customer Service: 877-lumenis Web site: http://www.lumenis.com

TAG: UltraPulse SurgiTouch Laser System

Dual offset femoral stems, hip stems that provide unique and competitive features.

Cementless hip stem revisions offering optimal version setting for each patient. Compatible with modular link ceramic or cobalt chromium femoral heads with up to 4 neck lengths, or the link saddle de

The proximally modular S-ROM Total Hip System provides custom capability at non-custom prices and is competitive with conventional porous coated systems.

Exactech's AcuMatch C-Series (Cemented Femoral Stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty.

Medicine Products:

Perfecta IMC Slim Neck The Modular Revision Hip Stem S-ROM Femoral Stems - Long Length Stems 36mm Neck with 21mm Calcar Replacement + Lat Neck Calcar Stem

(Date:5/15/2008)...irstCall/ -- Genesis,Pharmaceuticals Enterprises, ..."Company"), a U.S. pharmaceutical company with its...China, today announced its financial results,for t...rd quarter of its,fiscal year ended June 30, 2008.....S. Securities Exchange Commission that is availab...

(Date:5/15/2008)...irstCall/ -- Alexza,Pharmaceuticals, Inc. (Nasdaq:...joined the company as Vice President, Quality. He ...execution of quality program,strategies for Alexza...ical,product candidates. Mr. Parra was most recent..., Inc. in Palo Alto, California, where he was empl...

(Date:5/15/2008)...nsive Healthcare Plans, Long Term Care Will C...KLAND, Wash., May 15 /PRNewswire-USNewswire/ -- Wi... "Probably," says Cameron Truesdell,CEO of one of...rance,agencies, LTC Financial Partners LLC. Will t...Cain,s -- cover all healthcare needs? "Absolutely,...

(Date:5/15/2008)...-- Congresswoman Lois Capps,(D-CA) and the staff o...d a,briefing for key staff members of the House, o...s., WHEN: Monday, May 19th at 2 PM, WHERE: Ray...cussants includes Mary Hesdorffer, a nurse practit... Applied Research Foundation, who,specializes in a...

[0] Genesis Pharmaceuticals Reports Results for the Third Quarter of Fiscal Year 2008 [0] Carlos A. Parra Joins Alexza Pharmaceuticals as Vice President, Quality [0] Don't Wait for the Election to Plan Your Long-Term Healthcare, Insurance Leader Advises [0] Media Advisory: May 19 Briefing on Asbestos Legislature

... have successfully identified a molecule, which co... to stop growing cancers. The findings of the stud...pears in the online edition of the journal Nature ... Medical Centre in Holland jointly conducted the s...

... by Cuba to help Pakistan recover from the devasta...le human lives, in October last year//. 'Two more...ics have been donated to the government of Pakista...l. Muhammad Usman clarified. Cuba's First Deputy ...

...ysiological levels of zinc has been developed by U... new approach to study human diseases at a cellula...illions of health-conscious people, has remained a...ts role in Alzheimer's disease, stroke and other h...

...l warming in the East African highlands could have...rch by an international team places a certain impo...s spread, along with other factors like drug and p...nd human migration. University of Michigan theoret...

Other Medicine News:

Scientists Identify Key Element For Future Cancer Vaccine Quake-Hit Pakistan Receives 30 Field Hospitals From Cuba Novel Metal Detector To Measure Zinc Level In Humans The heat is on: Warm up time for Malaria’s clim

(Date:5/15/2008)...nd, May 15 /- Patients with breast or... cancers, can expect,further treatment advances wi...tuzumab) following new data that is being presente...y (ASCO) annual meeting in Chicago at,the end of M...meeting which,is the premier event for cancer ther...

(Date:5/15/2008)...ented at ASCO Showed Acceptable Tolerability Profi...4 Neuropathy, WOODCLIFF LAKE, N.J., May 15 /PRNew...nt eribulin mesylate (E7389) demonstrated activity...locally advanced or metastatic,breast cancer, acco...al,trial. The study also suggests that eribulin me...

(Date:5/15/2008)...tions demonstrated in Blacks, Hispanics/Latinos, P...ividuals, PARSIPPANY, N.J., May 15 /...presented at the American Society of,Hypertension,...8) in New,Orleans demonstrated that the powerful c...n medoxomil) safely and effectively helped,patient...

(Date:5/15/2008)...erland, May 15 /- Ergonex Pharma toda...dministration (FDA) has,granted orphan drug design...arterial hypertension (PAH). Terguride is currentl...ial in Europe., "The FDA,s grant of orphan drug d...engthens our development program by offering regul...

Breaking Medicine Technology:New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 2 New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 3 New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 4 New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 5 New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients 6 Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2 Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6 Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7 Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension 2 Virtual Reality Therapy May Help PTSD Patients 18642 1 Virtual Reality Therapy May Help PTSD Patients 18642 2 Virtual Reality Therapy May Help PTSD Patients 18642 3 Immune system pathway identified to fight allergens asthma 18641 1 Immune system pathway identified to fight allergens asthma 18641 2 Boston Medical Center Boston University School of Medicine researcher receives award 18638 1 Boston Medical Center Boston University School of Medicine researcher receives award 18638 2 Boston Medical Center Boston University School of Medicine researcher receives award 18638 3 Nitrates in vegetables protect against gastric ulcers 3214 1 Nitrates in vegetables protect against gastric ulcers 3214 2 Nitrates in vegetables protect against gastric ulcers 3214 3 Nitrates in vegetables protect against gastric ulcers 3214 4 Nitrates in vegetables protect against gastric ulcers 3214 5

[0] New Roche Data to be Presented at ASCO Offers Further Hope for Cancer Patients [0] Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer [0] Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations [0] Terguride Receives FDA Orphan Drug Designation for the Treatment of Pulmonary Arterial Hypertension

...LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abrax...global biopharmaceutical,company, discussed result...nce for chemotherapy induced angiogenesis and,rati...r Injectable,Suspension (paclitaxel protein-bound ...d)) with VEGF inhibitor drugs like,bevacizumab (Av...

...LOS ANGELES--(BUSINESS WIRE)--Apr 19, 2007 - Abrax...global biopharmaceutical,company, announced result...ole of SPARC (secreted protein acidic and rich in,...rticle,albumin-bound (nab(TM)) tumor-targeting tec...r Research (AACR) Annual Meeting held,April 14-18,...

Abraxis BioScience Presents Data from Pre-Clinical Study That,Provide Evidence for Chemotherapy-Induced Angiogenesis and,Rationale for Combining nab-Paclitaxel (Abraxane) with,Anti-Angiogenic Agents to Increase Tumor Response Abraxis BioScience Presents Pre-Clinical Findings That Support Role,of SPARC Expression in Cancer and the Role of the Nanoparticle,Albumin Bound (nab) Technology Platform in Targeting the Pathway